Shock Wave Application Increases the Antineoplastic Effect of Molecular Iodine Supplement in Breast Cancer Xenografts
| Autor: | Carmen Aceves, Luz M. López-Marín, Evangelina Delgado-González, Blanca E. Millán-Chiu, Carolina Muñoz-Torres, Francisco Fernández, Julia Rodríguez-Castelán, Brenda Anguiano, Achim M. Loske, Mirle Peña, Giovana Carrasco |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Acoustics and Ultrasonics medicine.medical_treatment Biophysics chemistry.chemical_element Breast Neoplasms Iodine High-Energy Shock Waves Mice Random Allocation 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Breast cancer SOX2 medicine Animals Humans Radiology Nuclear Medicine and imaging Radiological and Ultrasound Technology biology Chemistry CD44 medicine.disease Combined Modality Therapy Vascular endothelial growth factor 030104 developmental biology 030220 oncology & carcinogenesis Cancer cell Cancer research biology.protein Heterografts Female Stem cell Adjuvant Neoplasm Transplantation |
| Zdroj: | Ultrasound in Medicine & Biology. 46:649-659 |
| ISSN: | 0301-5629 |
| DOI: | 10.1016/j.ultrasmedbio.2019.11.015 |
| Popis: | We evaluated the effect of oral molecular iodine supplementation and shock wave application under three different conditions on human MDA-MB231 cancer cell xenografts. After tumor volume reached 1 cm3, mice were randomly assigned to groups and treated for 3 weeks. The results revealed that high-dose shock wave treatment (150 shock waves at a pressure of 21.7 MPa, SW150/21.7) generated tissue lesions without decreasing tumor growth, canceled the antineoplastic action of iodine and promoted pro-tumor conditions (increased hypoxia-induced factor [HIF] and vascular endothelial growth factor [VEGF]). In contrast, moderate (SW35/21.7) and low (SW35/9.9) doses of shock waves had significant antineoplastic effects and, in combination with iodine supplement, attenuated the aggressiveness of these cells by decreasing expression of the markers of stem cells (CD44 and Sox2) and invasion (HIF and VEGF). These results allow us to propose the combination of shock waves and iodine as a possible adjuvant in breast cancer therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|